CompanyGraph
Xi'an International Medical Investment Co. Ltd.
000516 · SZSE · China
000516.cnFinancials as of FY2025
At a glance
- Depends onDownstream position: depends on 12 industries, supplies 7
- ScaleMarket cap is $1.4B, above the global median of $1.15B
- PositionGross margin is 10%, lower than 95% of its Medical Care Facilities peers (median 32.8%)
Sign in to view price data.
Sign inThe reported statements, read against the company's own industry.
Financials view
Market Capitalization
9.45BCNY1.40B · vs all stocks (USD)
Revenue (TTM)
4.05BCNY600.14M · vs all stocks (USD)
Profit Margin
-6.30%vs Medical Care Facilities peers
Beta
0.1550xvs all stocks
52-Week Change
-22.71%vs all stocks
Market Capitalization
9.45BCNY1.40B · vs all stocks (USD)
Enterprise Value
13.12BCNY1.95B · vs all stocks (USD)
Forward P/E
32.46xvs Medical Care Facilities peers
Price to Sales (TTM)
2.33xvs Medical Care Facilities peers
Price to Book (MRQ)
2.89xvs Medical Care Facilities peers
Enterprise to Revenue
3.24xvs Medical Care Facilities peers
Enterprise to EBITDA
31.01xvs Medical Care Facilities peers
Gross Margin
9.96%vs Medical Care Facilities peers
Profit Margin
-6.30%vs Medical Care Facilities peers
Operating Margin
-4.20%vs Medical Care Facilities peers
Return on Assets (TTM)
-1.48%vs Medical Care Facilities peers
Return on Equity (TTM)
-11.53%vs Medical Care Facilities peers
Revenue (TTM)
4.05BCNY600.14M · vs all stocks (USD)
Revenue per Share (TTM)
1.81CNYUpdated Aug 18, 2026Quarterly Revenue Growth
-2.80%vs Medical Care Facilities peers
Gross Profit (TTM)
362.19MCNY53.71M · vs all stocks (USD)
EBITDA (TTM)
415.81MCNY61.66M · vs all stocks (USD)
Net Income (TTM)
-255.06MCNY-37.83M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
-19.83%vs Medical Care Facilities peers
Operating Cash Flow (TTM)
1.28BCNY190.14M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
434.56MCNY64.44M · vs all stocks (USD)
5-Year Average Dividend Yield
1.37%vs all stocks
Payout Ratio
0.00%vs Medical Care Facilities peers
Minority Interest (Equity)
-310.89MCNYFY2025 · Dec 31, 2025Revenue
4.07BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.74BCNYFY2025 · Dec 31, 2025Gross Profit
336.41MCNYFY2025 · Dec 31, 2025Operating Income
-300.14MCNY-44.51M · vs all stocks (USD)
Pre-tax Income
-400.30MCNYFY2025 · Dec 31, 2025Income Tax Expense
20.73MCNYFY2025 · Dec 31, 2025Net Income
-421.03MCNYFY2025 · Dec 31, 2025EBIT
-262.41MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
415.81MCNYFY2025 · Dec 31, 2025Research & Development
7.63MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
210.46MCNYFY2025 · Dec 31, 2025Other Operating Expenses
82.91MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
3.84MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
137.89MCNYFY2025 · Dec 31, 2025EPS (Basic)
-0.1400CNYFY2025 · Dec 31, 2025EPS (Diluted)
-0.1400CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
2.24BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
2.24BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-421.03MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
107.95MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
-63.09MCNYFY2025 · Dec 31, 2025Free Cash Flow
-291.36MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
389.14MCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-421.03MCNYFY2025 · Dec 31, 2025Other Non-cash Items
153.93MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
177.74MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
26.27MCNYFY2025 · Dec 31, 2025Capital Expenditures
-228.28MCNYFY2025 · Dec 31, 2025Purchase of Investments
-1.00MCNYFY2025 · Dec 31, 2025Sale of Investments
102.16MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-127.11MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
493.01MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.59BCNYFY2025 · Dec 31, 2025Common Dividends Paid
-149.21MCNYFY2025 · Dec 31, 2025Other Financing Charges
-59.38MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-1.31BCNYFY2025 · Dec 31, 2025Shares Outstanding
2.24BSharesUpdated Aug 18, 2026Float Shares
1.55BSharesUpdated Aug 18, 2026% Held by Insiders
33.24%vs all stocks
% Held by Institutions
1.06%vs all stocks
Total Cash (MRQ)
386.33MCNY57.29M · vs all stocks (USD)
Total Cash per Share (MRQ)
0.1730CNYUpdated Aug 18, 2026Total Debt (MRQ)
4.28BCNY635.39M · vs all stocks (USD)
Total Debt to Equity (MRQ)
1.46xvs Medical Care Facilities peers
Current Ratio (MRQ)
0.2470xvs Medical Care Facilities peers
Book Value per Share (MRQ)
1.46CNYUpdated Aug 18, 2026Total Assets
9.71BCNY1.44B · vs all stocks (USD)
Total Current Assets
1.13BCNYFY2025 · Dec 31, 2025Total Liabilities
6.70BCNYFY2025 · Dec 31, 2025Total Non-current Assets
8.58BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
2.25BCNYFY2025 · Dec 31, 2025Total Current Liabilities
4.45BCNYFY2025 · Dec 31, 2025Cash
388.96MCNYFY2025 · Dec 31, 2025Cash Equivalents
22.47MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
411.44MCNYFY2025 · Dec 31, 2025Other Short-term Investments
12.92MCNYFY2025 · Dec 31, 2025Accounts Receivable
518.62MCNYFY2025 · Dec 31, 2025Inventory
67.23MCNYFY2025 · Dec 31, 2025Accounts Payable
1.73BCNYFY2025 · Dec 31, 2025Short-term Debt
2.06BCNYFY2025 · Dec 31, 2025Other Current Liabilities
415.09KCNYFY2025 · Dec 31, 2025Long-term Debt
2.17BCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
7.41MCNYFY2025 · Dec 31, 2025Common Stock (Book)
2.24BCNYFY2025 · Dec 31, 2025Retained Earnings
-293.10MCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
3.01BCNY445.98M · vs all stocks (USD)
52-Week Low
3.82CNYUpdated Aug 18, 202652-Week High
6.19CNYUpdated Aug 18, 202652-Week Change
-22.71%vs all stocks
Beta
0.1550xvs all stocks
50-Day MA
4.12CNYUpdated Aug 18, 2026200-Day MA
4.61CNYUpdated Aug 18, 2026Avg 10-Day Volume
25.90MSharesUpdated Aug 18, 2026Avg 30-Day Volume
29.73MSharesUpdated Aug 18, 2026Diluted EPS (TTM)
-0.1100CNYUpdated Aug 18, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Gross margin is 10%, lower than 95% of its Medical Care Facilities peers (median 32.8%)Significant
Gross margin: 0.10Industry median: 0.33Industry P5: 0.11Peers compared: 32.00
Operating margin is -4.2%, lower than 95% of its Medical Care Facilities peers (median 11.1%)Significant
Operating margin: -0.04Industry median: 0.11Industry P5: -0.01Peers compared: 32.00
Current ratio is 0.25×, lower than 95% of its Medical Care Facilities peers (median 1.22×)Significant
Current ratio: 0.25Industry median: 1.22Industry P5: 0.65Peers compared: 32.00
Financial Health
Altman Z-Score 0.72: distress zoneCritical
Altman Z-Score: 0.72
Supply Chain
Downstream position: depends on 12 industries, supplies 7Notable
Outgoing: 7.00Incoming: 12.00
High connectivity hub: 19 industry connectionsNotable
Total Connections: 19.00
Scale
Market cap is $1.4B, above the global median of $1.15BNotable
Market cap (USD): 1,401,159,799.245Global Median: 1,146,734,693.424
Revenue is $600.14M, above the global median of $520.53MNotable
Revenue (USD): 600,143,685.99Global Median: 520,528,949.311
Levered free cash flow is $64.44M, above the global median of $16.24MNotable
Levered free cash flow (USD): 64,444,574.125Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
OMH Science Group Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Fsilon Furnishing and Construction Company Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Taiwan Fertilizer Co. Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Kunshan Kersen Science & Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
FMC Corporation
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Shenzhen Noposin Crop Science Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Darbond Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Xinjiang Machinery Research Institute Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionSenseMakingRule
Luolai Lifestyle Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowInterface
Zhongmin Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRule